GlassScriptPhysician profile
Parker D Freels
NPI 1497249973
$4,698.60
in general payments reported to CMS, 2019-2025
11 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $599 · 2023: $2,087 · 2024: $1,647 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,765 · Travel and Lodging: $985 · Education: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,765.08 |
| Travel and Lodging | $985.35 |
| Education | $200.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,488.09 | 2023-2024 | Ruby Coil, Indigo System |
| Medtronic, INC. | $860.95 | 2022-2024 | Concertotm, Solitaire X, Pipeline |
| Boston Scientific Corporation | $833.99 | 2023-2024 | Embold Fibered |
| Imperative Care, INC | $374.66 | 2024-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Sirtex Medical INC | $294.75 | 2024-2025 | Sir-Spheres Microspheres |
| Cook Medical LLC | $186.41 | 2022-2023 | Zenith Spiral-Z |
| Canon Medical Systems USA, INC. | $181.20 | 2022 | |
| Stryker Corporation | $162.15 | 2023-2024 | Spinejack |
| W. L. Gore & Associates, INC. | $148.66 | 2021 | |
| Galvanize Therapeutics, INC | $129.98 | 2025 | Aliya System |
| Balt USA, LLC | $37.76 | 2024-2025 | Prestige Coil System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parker Freels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.